Integrated Wealth Concepts’s Bio-Rad Laboratories Class A BIO Stock Holding History

Integrated Wealth Concepts’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.9K	Buy	+92	New	+$26.1K	﹤0.01%	3847

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Integrated Wealth Concepts's BIO Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 92 shares worth $26.9K. The stake represents ﹤0.01% of the portfolio and ranks #3847 among its holdings.

397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Integrated Wealth Concepts held 92 shares of Bio-Rad Laboratories Class A worth $26.9K as of Q2 2026.
Bio-Rad Laboratories Class A was a new Integrated Wealth Concepts position in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3847 holding.
397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.